OT4B is a company born from collaboration between academic research and stakeholders involved in scientific development projects in the field of rare diseases.
The company, in collaboration with Toulouse University Hospital, is conducting a research program focused on nenates and infants with Prader-Willi Syndrome. This program aims to study the characteristics of oxytocin in this population.
